技术领域Technical Field
本发明涉及医疗器械技术领域，更具体地说，它涉及一种智能管理胰岛素注射的装置。The present invention relates to the technical field of medical devices, and more specifically, to a device for intelligently managing insulin injection.
背景技术Background technique
目前现有的对于规范化胰岛素注射的工具为一套胰岛素定位卡。包括腹部定位卡，上臂定位卡和腿部定位卡，其中它的使用方式是将定位卡用手固定在注射部位处，再根据注射卡的定位点进行注射。每个点位有标记顺序数字帮助患者进行胰岛素注射，其中腹部定位卡有28个点位，上臂定位卡有7个定位点，腿部注射卡有14个定位点。The current tool for standardized insulin injection is a set of insulin positioning cards. It includes an abdominal positioning card, an upper arm positioning card, and a leg positioning card. The method of use is to fix the positioning card at the injection site by hand, and then inject according to the positioning point on the injection card. Each point is marked with a sequential number to help patients inject insulin. The abdominal positioning card has 28 points, the upper arm positioning card has 7 positioning points, and the leg injection card has 14 positioning points.
在真实的使用过程中，这套定位卡目前不能满足以下要点：In actual use, this set of positioning cards currently cannot meet the following points:
1、特殊人群包括妊娠期患者的使用，因为它并不包括除去腹部肚脐周围、上臂和大腿以外的其他区域，如：腰部中前侧、臀部上方这些区域；1. Special populations include pregnant patients, because it does not include other areas except the navel, upper arms and thighs, such as the front and middle waist and the upper buttocks;
2、由于糖尿病的特殊性患者中不乏体型处在极端情况的人群存在，每个人的个体差异化较大，同一型号的套卡不能满足这一部分人群的使用；2. Due to the particularity of diabetes, there are many people with extreme body shapes among patients, and each person has great individual differences. The same type of card set cannot meet the needs of this part of the population;
3、有的患者体内存在影响胰岛素注射的皮下脂肪增生，目前这套工具不能做到在每次的注射过程中准确地规避开不可以注射的区域；3. Some patients have subcutaneous fat hyperplasia that affects insulin injection. Currently, this tool cannot accurately avoid the area that cannot be injected during each injection.
4、同时发现患者需要在注射过程中始终利用一只手来维持这套定位卡待在注射区域，只有一只手可以用来进行注射行为，这种行为存在一定的隐患如需要搭配捏皮进行注射的患者没有办法进行注射，这样会导致胰岛素注射的深度不够，影响效果；4. It was also found that patients need to use one hand to keep the positioning card in the injection area during the injection process. Only one hand can be used for injection. This behavior has certain hidden dangers. For example, patients who need to pinch the skin for injection cannot inject. This will result in insufficient depth of insulin injection and affect the effect.
5、另外对于医护人员来说，不能明确地将不可以注射的区域告知患者，目前常用的例如腹部左上方或者肚脐周围3厘米的范围的这些说法均为较笼统的说法，当到患者进行注射时不能保证他找到的范围和医护人员描述的区域是完全相同的，归其原因依旧还是不可注射的带有皮下脂肪增生的区域没有得到很好的可视化准确化的可视化转化；5. In addition, medical staff cannot clearly inform patients of the areas that cannot be injected. Currently, commonly used terms such as the upper left abdomen or the 3 cm area around the navel are relatively general terms. When the patient is given an injection, there is no guarantee that the area he finds is exactly the same as the area described by the medical staff. The reason is that the area with subcutaneous fat hyperplasia that cannot be injected has not been well visualized and accurately converted;
6、对于患者是否进行良好的胰岛素注射以及皮下脂肪增生的变化情况，目前经验丰富的医护人员可以通过触诊的方式判断增生变化情况，以此来判断患者的胰岛素注射效果，但这种能力需要长久的经验来支撑，并且脂肪增生的大小具体变化还是需要其他手段进行测量才能得到精准化的数据。6. Regarding whether the patient has a good insulin injection and the changes in subcutaneous fat hyperplasia, experienced medical staff can currently judge the changes in hyperplasia by palpation to judge the effectiveness of the patient's insulin injection, but this ability requires long-term experience to support it, and the specific changes in the size of fat hyperplasia still need to be measured by other means to obtain accurate data.
为帮助使用者更好地进行胰岛素精准化规范化的注射，发明设计了一套可以帮助患者和医护人员智能管理胰岛素注射的装置。In order to help users better perform accurate and standardized insulin injections, a device was invented and designed to help patients and medical staff intelligently manage insulin injections.
发明内容Summary of the invention
针对现有技术存在的不足，本发明的目的在于提供一种智能管理胰岛素注射的装置，利用其具有智能识别皮下脂肪增生并实现注射点位区分手段，实现了自动实现被筛查患者的注射部位管理，通过自动定制胰岛素规范注射卡的设置实现一人一卡的特点，对胰岛素注射进行了有效管理。In view of the shortcomings of the prior art, the purpose of the present invention is to provide a device for intelligently managing insulin injections. By utilizing its ability to intelligently identify subcutaneous fat hyperplasia and distinguish injection points, it is possible to automatically manage the injection sites of screened patients. By automatically customizing the setting of standardized insulin injection cards, one card per person is achieved, thereby effectively managing insulin injections.
为实现上述目的，本发明提供了一种智能管理胰岛素注射的装置，包括胰岛素规范注射卡、红外热成像扫描装置、终端装置、智能桌垫、胰岛素注射点位识别与控制配件和注射点使用顺序可视化处理配套记录装置，所述红外热成像扫描装置通过皮下脂肪增生存在区域筛查进行患者注射区域选择，所述胰岛素注射点位识别与控制配件识别和筛选患者的颜色标记点、并在筛选后实现注射作业，所述胰岛素规范注射卡采样患者标本，经过智能桌垫和终端装置识别并控制胰岛素规范注射卡标记形成注射后标记后胰岛素注射规范卡，所述注射点使用顺序可视化处理配套记录装置对胰岛素规范注射卡和注射后标记后胰岛素注射规范卡标识记录，其中：所述红外热成像扫描装置通过脂肪初筛后对注射区域进行配准扫描、生成同一样本的两张胰岛素规范注射卡后进行对比筛选，所述红外热成像扫描装置通过计算判定并选择患者的注射区域；所述智能桌垫内设有信息接收模块，所述智能桌垫设有若干个注射点位的加工区域，所述智能桌垫通过信息接收模块接收胰岛素规范注射卡型号和位置的电信号，所述智能桌垫通过电信号控制加工区域内各点位的电性连接，所述智能桌垫通过设置的加热装置对加工区域进行加热，所述胰岛素规范注射卡的内部开设有若干个注射区域，所述注射区域内可标注注射点位，所述胰岛素注射规范卡置入智能桌垫的对应加工区域，使注射点位变色从而获得不同标识颜色注射点的胰岛素注射规范卡。To achieve the above-mentioned purpose, the present invention provides a device for intelligently managing insulin injections, including a standardized insulin injection card, an infrared thermal imaging scanning device, a terminal device, an intelligent table mat, insulin injection point identification and control accessories, and a matching recording device for visual processing of the injection point usage order, wherein the infrared thermal imaging scanning device selects the patient's injection area by screening the area where subcutaneous fat hyperplasia exists, the insulin injection point identification and control accessories identify and screen the patient's color marking points, and perform the injection operation after screening, the standardized insulin injection card samples the patient's specimen, and the intelligent table mat and the terminal device identify and control the standardized insulin injection card mark to form a standardized insulin injection card with post-injection marking, the matching recording device for visual processing of the injection point usage order records the standardized insulin injection card and the standardized insulin injection card with post-injection marking, wherein: the infrared thermal imaging The scanning device performs registration scanning on the injection area after the initial fat screening, generates two insulin standard injection cards of the same sample, and then performs comparative screening. The infrared thermal imaging scanning device determines and selects the patient's injection area through calculation; an information receiving module is provided in the smart table mat, and the smart table mat is provided with processing areas for several injection points. The smart table mat receives the electrical signal of the model and position of the insulin standard injection card through the information receiving module, and the smart table mat controls the electrical connection of each point in the processing area through the electrical signal. The smart table mat heats the processing area through the heating device provided. Several injection areas are opened inside the insulin standard injection card, and the injection points can be marked in the injection area. The insulin injection standard card is placed in the corresponding processing area of the smart table mat to change the color of the injection point, thereby obtaining an insulin injection standard card with injection points of different marking colors.
优选的，一种智能管理胰岛素注射的装置，所述胰岛素注射点位识别与控制配件包括颜色识别传感器和机械控制配件，所述颜色识别传感器设置在胰岛素注射器的两端并用于识别点位颜色，所述机械控制配件连接在胰岛素注射器的开关处并控制胰岛素注射器注射。Preferably, a device for intelligently managing insulin injections is provided, wherein the insulin injection point identification and control accessories include a color recognition sensor and a mechanical control accessory, wherein the color recognition sensor is arranged at both ends of the insulin syringe and is used to identify the point color, and the mechanical control accessory is connected to the switch of the insulin syringe and controls the injection of the insulin syringe.
优选的，一种智能管理胰岛素注射的装置，所述胰岛素规范注射卡的两侧均设置有生物硅胶，所述胰岛素规范注射卡通过生物硅胶与患者皮肤贴合。Preferably, in a device for intelligently managing insulin injection, both sides of the standard insulin injection card are provided with bio-silicone, and the standard insulin injection card is attached to the patient's skin through the bio-silicone.
优选的，一种智能管理胰岛素注射的装置，所述红外热成像扫描装置对胰岛素规范注射卡进行离散程度计算，并通过离散程度计算的结果判定患者的注射区域增生状态。Preferably, in a device for intelligently managing insulin injection, the infrared thermal imaging scanning device calculates the degree of discreteness of a standard insulin injection card, and determines the hyperplasia state of the patient's injection area through the result of the discrete degree calculation.
优选的，一种智能管理胰岛素注射的装置，所述注射点位通过胰岛素规范注射卡、红外热成像扫描装置和智能桌垫识别判定后，通过胰岛素注射点位识别与控制配件选择注射。Preferably, a device for intelligently managing insulin injections is provided, wherein the injection site is identified and determined by an insulin standard injection card, an infrared thermal imaging scanning device and an intelligent table mat, and the injection is selected through the insulin injection site identification and control accessories.
优选的，一种智能管理胰岛素注射的装置，所述注射点使用顺序可视化处理配套记录装置包括胰岛素规范注射卡收集以及胰岛素规范注射卡上注射点位和注射顺序识别的收集仓。Preferably, a device for intelligently managing insulin injections, wherein the injection point use sequence visualization processing supporting recording device includes a collection bin for collecting insulin standard injection cards and identifying the injection points and injection sequence on the insulin standard injection cards.
优选的，一种智能管理胰岛素注射的装置，所述注射点使用顺序可视化处理配套记录装置及其内部设置的收集仓供患者胰岛素注射实际情况的评估。Preferably, a device for intelligently managing insulin injections, wherein the injection points use a sequential visualization processing supporting recording device and a collection bin disposed therein for evaluating the actual insulin injection situation of the patient.
综上所述，本发明综合的有益效果在于：In summary, the comprehensive beneficial effects of the present invention are:
该智能管理胰岛素注射的装置，本发明可以更加智能化地管理患者在胰岛素注射过程中的注射行为，使其养成良好的规范的注射习惯，有效地避免因不当注射产生皮下脂肪增生的概率，结合红外热成像技术对注射点位科学地做出区分，使患者在注射过程中可以有效避免不可注射区域；The device for intelligently managing insulin injection can more intelligently manage the injection behavior of patients during insulin injection, so that they can develop good and standardized injection habits, effectively avoid the probability of subcutaneous fat hyperplasia caused by improper injection, and scientifically distinguish the injection points by combining infrared thermal imaging technology, so that patients can effectively avoid non-injectable areas during the injection process;
该智能管理胰岛素注射的装置，本发明可以有效帮助医护人员将患者的注射行为以及皮下脂肪增生的变化情况进行可视化呈现，通过注射区域内的点位的使用情况以及皮下脂肪增生对应点位位置信息的变化情况，可以有效地获取患者注射习惯是否良好；The device for intelligently managing insulin injection can effectively help medical staff visualize the injection behavior of patients and the changes in subcutaneous fat hyperplasia. Through the use of points in the injection area and the changes in the position information of the corresponding points of subcutaneous fat hyperplasia, it can effectively obtain whether the patient's injection habits are good.
该智能管理胰岛素注射的装置，本发明可以有效地针对每一位患者定制化制定其胰岛素注射的相关规范，一对一地进行胰岛素注射计划的制定；同时材质的选择可以解放出双手，注射过程中更加安全；The device for intelligently managing insulin injection can effectively customize the relevant specifications of insulin injection for each patient and formulate a one-to-one insulin injection plan. At the same time, the choice of materials can free both hands, making the injection process safer.
该智能管理胰岛素注射的装置，本发明可以有效地实现对注射人群、注射区域的全覆盖，并且实现对注射区域的定位，通过定位点加定位尺集合医护人员的操作可以使患者精准地找到最佳的注射区域范围，降低注射同一注射点位的可能性，有效降低皮下脂肪增生产生和恶化的概率。The device for intelligently managing insulin injection can effectively achieve full coverage of the injection population and injection areas, and realize the positioning of the injection areas. By combining the positioning points and the positioning ruler with the operation of medical staff, the patient can accurately find the best injection area range, reduce the possibility of injecting the same injection point, and effectively reduce the probability of the occurrence and deterioration of subcutaneous fat hyperplasia.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚的说明本发明具体实施方式或现有技术中的技术方案，下面将对具体实施方式或现有技术中描述所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图仅仅是本发明的一种实施方式，对于本领域普通技术人员来说，在不付出创造性劳动的前提下，还可以根据这些附图获得其他的附图。In order to more clearly illustrate the specific implementation of the present invention or the technical solution in the prior art, the drawings required for describing the specific implementation or the prior art will be briefly introduced below. Obviously, the drawings described below are only one implementation of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
图1为本发明实施例中使用流程示意图；FIG1 is a schematic diagram of a process flow diagram of an embodiment of the present invention;
图2为本发明实施例中小号腹部胰岛素注射规范卡标注示意图；FIG2 is a schematic diagram of a labeling diagram of a small size abdominal insulin injection standard card according to an embodiment of the present invention;
图3为本发明实施例中小号腹部胰岛素注射规范卡标注示意图；FIG3 is a schematic diagram of a marking on a small size abdominal insulin injection standard card according to an embodiment of the present invention;
图4为本发明实施例中上臂胰岛素注射定位卡标注示意图；FIG4 is a schematic diagram of an upper arm insulin injection positioning card marking according to an embodiment of the present invention;
图5为本发明实施例中上臂胰岛素注射定位卡标注示意图；FIG5 is a schematic diagram of an upper arm insulin injection positioning card marking according to an embodiment of the present invention;
图6为本发明实施例中腿部胰岛素注射定位卡标注示意图；FIG6 is a schematic diagram of a marking on a leg insulin injection positioning card according to an embodiment of the present invention;
图7为本发明实施例中腿部胰岛素注射定位卡标注示意图；FIG7 is a schematic diagram of a marking on a leg insulin injection positioning card according to an embodiment of the present invention;
图8为本发明实施例中小号腰部及臀部胰岛素注射定位卡标注示意图；FIG8 is a schematic diagram of a marking on a small waist and buttocks insulin injection positioning card according to an embodiment of the present invention;
图9为本发明实施例中小号腰部及臀部胰岛素注射定位卡标注示意图；FIG9 is a schematic diagram of a marking on a small waist and buttocks insulin injection positioning card according to an embodiment of the present invention;
图10为本发明实施例中注射点位筛选流程示意图；FIG10 is a schematic diagram of the injection point screening process according to an embodiment of the present invention;
图11为本发明实施例中图像配准方法示意图；FIG11 is a schematic diagram of an image registration method according to an embodiment of the present invention;
图12为本发明实施例中红外热成像扫描信息传输示意图；FIG12 is a schematic diagram of infrared thermal imaging scanning information transmission according to an embodiment of the present invention;
图13为本发明实施例中规范化注射方法1示意图；FIG13 is a schematic diagram of a standardized injection method 1 according to an embodiment of the present invention;
图14为本发明实施例中规范化注射方法2示意图；FIG14 is a schematic diagram of a standardized injection method 2 according to an embodiment of the present invention;
图15为本发明实施例中控制配件运转流程示意图；FIG15 is a schematic diagram of a control accessory operation flow chart in an embodiment of the present invention;
图16为本发明实施例中方法2的信号传输示意图；FIG16 is a schematic diagram of signal transmission of method 2 according to an embodiment of the present invention;
图17为本发明实施例中圆形卡片的颜色渐变排列顺序情况1示意图；FIG17 is a schematic diagram of a color gradient arrangement sequence of circular cards in an embodiment of the present invention;
图18为本发明实施例中圆形卡片的颜色渐变排列顺序情况2示意图；FIG18 is a schematic diagram of a color gradient arrangement sequence of circular cards in an embodiment of the present invention;
图19为本发明实施例中圆形卡片的颜色渐变排列顺序情况3示意图。FIG. 19 is a schematic diagram of the color gradient arrangement sequence 3 of the circular cards in an embodiment of the present invention.
具体实施方式Detailed ways
为使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解，下面对本发明具体实施方式中的技术方案进行清楚、完整的描述，以进一步阐述本发明，显然，所描述的具体实施方式仅仅是本发明的一部分实施方式，而不是全部的样式。In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the technical scheme in the specific implementation mode of the present invention is clearly and completely described below to further illustrate the present invention. Obviously, the specific implementation mode described is only a part of the implementation mode of the present invention, rather than all styles.
以下结合附图1-19对本发明作进一步详细说明。The present invention is further described in detail below with reference to Figures 1-19.
本发明提供一种技术方案：一种智能管理胰岛素注射的装置，本装置内共包括胰岛素规范注射卡，标记后胰岛素注射规范卡，红外热成像扫描装置，终端装置，智能桌垫，胰岛素注射点位识别与控制配件，注射点使用顺序可视化处理配套记录装置，所述红外热成像扫描装置通过皮下脂肪增生存在区域筛查进行患者注射区域选择，所述胰岛素注射点位识别与控制配件识别和筛选患者的颜色标记点、并在筛选后实现注射作业，所述胰岛素规范注射卡采样患者标本，经过智能桌垫和终端装置识别并控制胰岛素规范注射卡标记形成注射后标记后胰岛素注射规范卡，所述注射点使用顺序可视化处理配套记录装置对胰岛素规范注射卡和注射后标记后胰岛素注射规范卡标识记录，具体的，结合图1所示，具体的操作流程如下：The present invention provides a technical solution: a device for intelligently managing insulin injection, which includes a standardized insulin injection card, a marked standardized insulin injection card, an infrared thermal imaging scanning device, a terminal device, an intelligent table mat, an insulin injection point identification and control accessory, and a matching recording device for visual processing of the injection point usage sequence. The infrared thermal imaging scanning device selects the patient's injection area by screening the area where subcutaneous fat hyperplasia exists. The insulin injection point identification and control accessory identifies and screens the patient's color marking points and performs the injection operation after screening. The standardized insulin injection card samples the patient's specimen, and the standardized insulin injection card is identified and controlled by the intelligent table mat and the terminal device to form a marked standardized insulin injection card. The matching recording device for visual processing of the injection point usage sequence records the identification of the standardized insulin injection card and the marked standardized insulin injection card. Specifically, as shown in FIG1 , the specific operation process is as follows:
准备工作：确定患者的适配的规范注射卡，本装置包括儿童、青少年、成年人、妊娠早期人群、妊娠中期人群、妊娠晚期人群共6种人群可供选择，每种人群的每个胰岛素注射部位的规范卡都包括大号胰岛素规范注射卡101和小号胰岛素规范注射卡102两种型号来适应糖尿病患者的体态特征，可根据每个人的体型选择适宜其后期进行胰岛素注射型号的胰岛素注射规范卡；Preparation: Determine the appropriate standard injection card for the patient. This device includes six groups of people to choose from, including children, adolescents, adults, early pregnancy, mid-pregnancy, and late pregnancy. The standard card for each insulin injection site for each group includes two models, large insulin standard injection card 101 and small insulin standard injection card 102, to adapt to the body characteristics of diabetic patients. You can choose the insulin injection standard card suitable for your later insulin injection according to your body shape;
规范卡根据注射人群和注射部位共包括儿童及青少年腹部胰岛素注射规范卡a10，儿童及青少年上臂胰岛素注射规范卡b10，儿童及青少年腿部胰岛素注射规范卡c10；成人腹部胰岛素注射规范卡a20，成人上臂胰岛素注射规范卡b20，成人腿部胰岛素注射规范卡c20；妊娠孕早期腹部胰岛素注射规范卡a30，妊娠期孕早期上臂胰岛素注射规范卡b30，妊娠期孕早期腿部胰岛素注射规范卡c30；妊娠期孕中期腰部及臀部胰岛素注射规范卡d10；妊娠期孕晚期腰部及臀部胰岛素注射规范卡d20。According to the injection population and injection site, the standard cards include standard card A10 for abdominal insulin injection in children and adolescents, standard card B10 for upper arm insulin injection in children and adolescents, standard card C10 for leg insulin injection in children and adolescents; standard card A20 for abdominal insulin injection in adults, standard card B20 for upper arm insulin injection in adults, standard card C20 for leg insulin injection in adults; standard card A30 for abdominal insulin injection in early pregnancy, standard card B30 for upper arm insulin injection in early pregnancy, standard card C30 for leg insulin injection in early pregnancy; standard card D10 for waist and buttocks insulin injection in mid-pregnancy; standard card D20 for waist and buttocks insulin injection in late pregnancy.
不同人群所使用的胰岛素规范注射卡之间用颜色来进行区分。例如成人规范卡套系为蓝色套系，儿童及青少年规范卡套系为绿色套系，妊娠期规范卡套系为粉色套系等等。The insulin injection standard cards used by different groups of people are distinguished by color. For example, the adult standard card set is a blue set, the child and adolescent standard card set is a green set, the pregnancy standard card set is a pink set, and so on.
具体的，a系列腹部胰岛素规范卡注射区域分为四个区域，每个区域有4排注射孔位且每个注射区域都采用不同透明度的统一颜色进行标注，每张小号腹部胰岛素注射卡面的每个区域内包含28个注射点位，整张卡面共包含112个注射点；每张大号注射规范卡面的每个区域内包含36个注射点位，整张卡面共包含144个注射点位，卡面中心直径5厘米的圆形区域为非注射区。Specifically, the injection area of the A series abdominal insulin specification card is divided into four areas, each area has 4 rows of injection holes and each injection area is marked with a uniform color of different transparency, each small-sized abdominal insulin injection card contains 28 injection points in each area, and the entire card contains a total of 112 injection points; each large-sized injection specification card contains 36 injection points in each area, and the entire card contains a total of 144 injection points. The circular area with a diameter of 5 cm in the center of the card is the non-injection area.
如图2和图3所示，小号腹部胰岛素注射规范卡a101的每一注射区域都有4排注射孔位，共有4个注射区域16排可注射孔位，分别用字母A-P来标记，每排包括7个注射点位，分别用1-7按照W/M轮换法则进行标注，大号腹部胰岛素注射规范卡a102的每一个注射区域都有4排注射孔位，共有4个注射区域16排可注射孔位，分别用字母A-P来标记，每排包括9个注射点位，分别用1-9按照W/M轮换法则进行标注，如图2、3所示。As shown in Figures 2 and 3, each injection area of the small abdominal insulin injection specification card a101 has 4 rows of injection holes, with a total of 4 injection areas and 16 rows of injectable holes, marked with letters A-P respectively, and each row includes 7 injection points, marked with 1-7 according to the W/M rotation rule. Each injection area of the large abdominal insulin injection specification card a102 has 4 rows of injection holes, with a total of 4 injection areas and 16 rows of injectable holes, marked with letters A-P respectively, and each row includes 9 injection points, marked with 1-9 according to the W/M rotation rule, as shown in Figures 2 and 3.
如图4和图5所示，b系列上臂胰岛素注射定位卡注射区域为一个区域，小号上臂胰岛素注射规范卡b101的注射区域共有4列注射孔位，分别用A-D来标记，每列包括5个注射点位，分别用1-5五个数字来按照W/M轮换法则进行标注，如图3所示，大号上臂胰岛素注射规范卡b102的注射区域共有6列注射孔位，分别用A-F来标记每列包括5个注射点位，分别用1-5五个数字按照W/M轮换法则进行标注，如图4、5所示。As shown in Figures 4 and 5, the injection area of the B series upper arm insulin injection positioning card is one area. The injection area of the small upper arm insulin injection specification card B101 has 4 columns of injection holes, marked with A-D respectively, and each column includes 5 injection points, which are marked with five numbers 1-5 according to the W/M rotation rule, as shown in Figure 3. The injection area of the large upper arm insulin injection specification card B102 has 6 columns of injection holes, marked with A-F respectively, and each column includes 5 injection points, which are marked with five numbers 1-5 according to the W/M rotation rule, as shown in Figures 4 and 5.
如图6和图7所示，c系列腿部胰岛素注射定位卡注射区域为一个注射区域，小号腿部胰岛素注射规范卡c101的注射区域共有6列注射孔位，分别用A-F来标记，每列包括7个注射点位，分别用1-7七个数字标识按照W/M轮换法则进行标注，如图2所示，大号腿部胰岛素注射规范卡c102的注射区域共有8列注射孔位 ，分别用A-H来标记，每列包括7个注射点位，分别用1-7七个数字按照W/M轮换法则进行标注，如图6、7所示。As shown in Figures 6 and 7, the injection area of the C series leg insulin injection positioning card is one injection area. The injection area of the small leg insulin injection specification card C101 has 6 columns of injection holes, marked with A-F respectively, and each column includes 7 injection points, which are marked with seven numbers 1-7 according to the W/M rotation rule, as shown in Figure 2. The injection area of the large leg insulin injection specification card C102 has 8 columns of injection holes, marked with A-H respectively, and each column includes 7 injection points, which are marked with seven numbers 1-7 according to the W/M rotation rule, as shown in Figures 6 and 7.
如图8和图9所示，d系列腰部及臀部胰岛素规范卡注射区域分为四个区域，每个区域有4排注射孔位且每个注射区域都采用不同颜色进行标注，每张小号腹部胰岛素注射卡面的每个区域内包含28个注射点位，整张卡面共包含112个注射点；每张大号注射规范卡面的每个区域内包含36个注射点位，整张卡面共包含144个注射点位，卡面中心直径5厘米的圆形区域为非注射区，相较于腹部胰岛素注射规范卡左右两侧的注射区域之间的距离要大许多。As shown in Figures 8 and 9, the injection area of the D-series waist and buttocks insulin specification card is divided into four areas, each area has 4 rows of injection holes and each injection area is marked with a different color. Each small-sized abdominal insulin injection card contains 28 injection points in each area, and the entire card contains a total of 112 injection points; each large-sized injection specification card contains 36 injection points in each area, and the entire card contains a total of 144 injection points. The circular area with a diameter of 5 cm in the center of the card is the non-injection area, which is much larger than the distance between the injection areas on the left and right sides of the abdominal insulin injection specification card.
具体的，小号腰部及臀部胰岛素注射卡d101的注射区域的每一注射区域都有4排注射孔位，共有4个注射区域16排可注射孔位，分别用字母A-P来标记，每排包括7个注射点位，分别用1-7按照W/M轮换法则进行标注，如图4所示，大号腹部胰岛素注射规范卡d102的每一个注射区域都有4排注射孔位，共有4个注射区域16排可注射孔位，分别用字母A-P来标记，每排包括9个注射点位，分别用1-9按照W/M轮换法则进行标注，如图8、9所示。Specifically, each injection area of the small waist and buttocks insulin injection card d101 has 4 rows of injection holes, and there are a total of 4 injection areas and 16 rows of injectable holes, which are marked with letters A-P respectively, and each row includes 7 injection points, which are marked with 1-7 according to the W/M rotation rule, as shown in Figure 4. Each injection area of the large abdominal insulin injection specification card d102 has 4 rows of injection holes, and there are a total of 4 injection areas and 16 rows of injectable holes, which are marked with letters A-P respectively, and each row includes 9 injection points, which are marked with 1-9 according to the W/M rotation rule, as shown in Figures 8 and 9.
作为本发明进一步的实施例，所述红外热成像扫描装置通过脂肪初筛后对注射区域进行配准扫描、生成同一样本的两张胰岛素规范注射卡后进行对比筛选，所述红外热成像扫描装置通过计算判定并选择患者的注射区域，所述红外热成像扫描装置对胰岛素规范注射卡进行离散程度计算，并通过离散程度计算的结果判定患者的注射区域增生状态，具体的，如图10所示，本实施例将对应的人群和选择的胰岛素注射规范卡的型号信息录入到患者终端设备30中的档案中，根据以上信息确定下一步进行红外热成像扫描的图像提取的区域位置和大小。As a further embodiment of the present invention, the infrared thermal imaging scanning device performs a registration scan on the injection area after an initial fat screening, generates two standard insulin injection cards of the same sample, and then performs comparative screening. The infrared thermal imaging scanning device determines and selects the patient's injection area through calculation. The infrared thermal imaging scanning device calculates the degree of discreteness of the standard insulin injection card, and determines the hyperplasia state of the patient's injection area according to the result of the discrete degree calculation. Specifically, as shown in Figure 10, this embodiment enters the corresponding population and the model information of the selected standard insulin injection card into the file in the patient terminal device 30, and determines the area position and size of the image extraction for the next step of infrared thermal imaging scanning based on the above information.
作为本发明进一步的实施例，结合图10所示，第一步到第四步的具体操作步骤如下：As a further embodiment of the present invention, in conjunction with FIG10 , the specific operation steps of the first step to the fourth step are as follows:
第一步：利用红外热成像技术实现对患者皮下脂肪增生存在区域的筛查。Step 1: Use infrared thermal imaging technology to screen the areas where subcutaneous fat hyperplasia exists in patients.
利用可连接在移动终端设备30（电脑、手机等）的红外热成像扫描装置20对患者进行扫描，得到患者全身的红外热成像图像并传输给终端设备，根据准备工作中录入的患者的胰岛素注射规范卡的使用位置以及大小型号信息，通过智能图形配准技术调取出胰岛素注射位置注射规范卡内覆盖的区域。医护人员的终端系统中包含有所有人群所有位置的胰岛素注射规范卡的电子版图像，且此版电子版图形中包含每一注射点的位置信息，将两版图像进行合并，使红外热成像截取图像中包含注射点的位置信息。下面是具体实现过程：The patient is scanned using an infrared thermal imaging scanning device 20 that can be connected to a mobile terminal device 30 (computer, mobile phone, etc.), and an infrared thermal imaging image of the patient's entire body is obtained and transmitted to the terminal device. According to the usage location and size information of the patient's insulin injection specification card entered in the preparation work, the area covered by the insulin injection specification card is retrieved through intelligent graphic registration technology. The terminal system of medical staff contains electronic images of insulin injection specification cards for all locations of all people, and this electronic version of the graphic contains the location information of each injection point. The two versions of the image are merged so that the infrared thermal imaging intercepted image contains the location information of the injection point. The following is the specific implementation process:
根据规范卡上的数字和字母标识，大号成人和妊娠期版本的腹部胰岛素注射规范卡的注射点的位置信息包括A1-A9、B1-B9、C1-C9、D1-D9、E1-E9、F1-F9、G1-G9、H1-H9、I1-I9、J1-J9、K1-K9、L1-L9、M1-M9、N1-N9、O1-O9、P1-P9。According to the numbers and letters on the specification card, the location information of the injection points on the large adult and pregnancy versions of the abdominal insulin injection specification card include A1-A9, B1-B9, C1-C9, D1-D9, E1-E9, F1-F9, G1-G9, H1-H9, I1-I9, J1-J9, K1-K9, L1-L9, M1-M9, N1-N9, O1-O9, and P1-P9.
小号成人和妊娠期版本的腹部胰岛素注射规范卡的注射点位的位置信息包括A1-A7、B1-B7、C1-C7、D1-D7、E1-E7、F1-F7、G1-G7、H1-H7、I1-I7、J1-J7、K1-K7、L1-L7、M1-M7、N1-N7、O1-O7、P1-P7。大号青少年及儿童版本的腹部胰岛素注射规范卡的注射点的位置信息包括A1-A5、B1-B5、C1-C5、D1-D5、E1-E5、F1-F5、G1-G5、H1-H5、I1-I5、J1-J5、K1-K5、L1-L5。The location information of the injection points on the small adult and pregnancy version of the abdominal insulin injection specification card includes A1-A7, B1-B7, C1-C7, D1-D7, E1-E7, F1-F7, G1-G7, H1-H7, I1-I7, J1-J7, K1-K7, L1-L7, M1-M7, N1-N7, O1-O7, P1-P7. The location information of the injection points on the large adolescent and children's version of the abdominal insulin injection specification card includes A1-A5, B1-B5, C1-C5, D1-D5, E1-E5, F1-F5, G1-G5, H1-H5, I1-I5, J1-J5, K1-K5, L1-L5.
小号青少年及儿童版本的腹部胰岛素注射规范卡的注射点的位置信息包括A1-A4、B1-B4、C1-C4、D1-D4、E1-E4、F1-F4、G1-G4、H1-H4、I1-I4、J1-J4、K1-K4、L1-L4。大号成人和妊娠期版本的腿部胰岛素注射规范卡的注射点的位置、信息包括A1-A7、B1-B7、C1-C7、D1-D7、E1-E7、F1-F7、G1-G7、H1-H7。The locations of the injection points on the small adolescent and children's version of the abdominal insulin injection specification card include A1-A4, B1-B4, C1-C4, D1-D4, E1-E4, F1-F4, G1-G4, H1-H4, I1-I4, J1-J4, K1-K4, and L1-L4. The locations and information of the injection points on the large adult and pregnancy version of the leg insulin injection specification card include A1-A7, B1-B7, C1-C7, D1-D7, E1-E7, F1-F7, G1-G7, and H1-H7.
小号成人和妊娠期版本的腿部胰岛素注射规范卡的注射点位的位置信息包括A1-A7、B1-B7、C1-C7、D1-D7、E1-E7、F1-F7。The location information of the injection points on the small adult and pregnancy versions of the leg insulin injection specification card include A1-A7, B1-B7, C1-C7, D1-D7, E1-E7, and F1-F7.
大号成人和妊娠期版本的上臂胰岛素注射规范卡的注射点的位置信息包括A1-A5、B1-B5、C1-C5、D1-D5、E1-E5、F1-F5。小号成人和妊娠版本的上臂胰岛素注射规范卡的注射点位的位置信息包括A1-A5、B1-B5、C1-C5、D1-D5。The location information of the injection points of the large adult and pregnancy versions of the upper arm insulin injection specification card includes A1-A5, B1-B5, C1-C5, D1-D5, E1-E5, and F1-F5. The location information of the injection points of the small adult and pregnancy versions of the upper arm insulin injection specification card includes A1-A5, B1-B5, C1-C5, and D1-D5.
通过比对注射部位中相邻注射点位对应测量出的温度，求得这些温度之间的方差，因为方差描述的是所得温度数值的离散程度，方差越大，数据分布越分散，这就代表这些注射点对应的皮下温度存在异常温度点位，这一步即可判定患者该注射区域是否存在增生。By comparing the temperatures measured at adjacent injection points in the injection site, the variance between these temperatures is obtained. This is because the variance describes the degree of discreteness of the obtained temperature values. The larger the variance, the more dispersed the data distribution, which means that there are abnormal temperature points in the subcutaneous temperatures corresponding to these injection points. This step can determine whether there is hyperplasia in the patient's injection area.
若判定为该区域是存在增生的情况，则要寻找异常温度对应的注射点位，需要将后续注射部位中涉及到的所有点位的温度进行由高到低或由低到高的排列，去除掉10%的最大温度值和10%的最小温度值，计算其余部分温度的平均值，将每一点位温度与平均值进行比较，把温度差大于5%的注射点位筛选并标记出来，记为异常注射点位，初步判定为不可注射点位。If it is determined that there is hyperplasia in the area, it is necessary to find the injection points corresponding to the abnormal temperatures. The temperatures of all points involved in the subsequent injection sites need to be arranged from high to low or from low to high, and 10% of the maximum temperature values and 10% of the minimum temperature values are removed. The average temperature of the remaining parts is calculated, and the temperature of each point is compared with the average value. The injection points with a temperature difference greater than 5% are screened and marked as abnormal injection points, and preliminarily determined as non-injectable points.
如图11所示将上述判断结果传输到医护人员的终端设备，医护人员可通过皮肤触诊进行二次判断，从而进一步提升上述得出的不可注射点位的准确性，同时终端设备会将该患者的本次测量结果进行记录，方便后期调取与查询。As shown in FIG11 , the above judgment results are transmitted to the terminal device of the medical staff. The medical staff can make a secondary judgment through skin palpation, thereby further improving the accuracy of the non-injectable points obtained above. At the same time, the terminal device will record the patient's measurement results for later retrieval and inquiry.
作为本发明进一步的实施例，所述智能桌垫内设有信息接收模块，所述智能桌垫内设有若干个注射点位的区域，所述智能桌垫通过信息接收模块接收胰岛素规范注射卡型号和位置的电信号，所述智能桌垫通过电信号控制加工区域内各点位的电性连接。As a further embodiment of the present invention, an information receiving module is provided in the smart table mat, and several injection point areas are provided in the smart table mat. The smart table mat receives electrical signals of the model and position of the insulin standard injection card through the information receiving module, and the smart table mat controls the electrical connection of each point in the processing area through the electrical signal.
第二步：将第一步筛选标记出来的不可注射点的位置信息以及患者后续将要使用的胰岛素注射规范卡的型号信息两者通过蓝牙或连接传输到智能桌垫40中。Step 2: Transmit the location information of the non-injectable points marked by the first step screening and the model information of the insulin injection specification card to be used by the patient later to the smart desk pad 40 via Bluetooth or connection.
智能桌垫40表面分为四大加工区域，分别是腹部胰岛素注射点位加工区域a40、上臂胰岛素注射点位加工区域b40、腿部胰岛素注射点位加工区域c40、妊娠人群特殊注射部位注射点位加工区域d40。The surface of the smart desk mat 40 is divided into four major processing areas, namely, abdominal insulin injection point processing area a40, upper arm insulin injection point processing area b40, leg insulin injection point processing area c40, and special injection site processing area d40 for pregnant women.
智能桌垫40中配有信息接收模块401a，401的主要功能是接收规范卡型号信息以及位置信息的信号的接收，规范卡型号识别可帮助智能桌垫确认并选择出四大区域中将要进行加热的区域，智能桌垫40中同时配备处理器401b401b与桌垫上所有注射点位都有电路连接，通过接收由主机端传输过来的不可注射点的位置信息的信号，控制桌垫相对应位置的点位的电路进行连接，加热装置402正常使用，达到通电使该点位的进行加热的效果，没有传输过来点位置信息就继续保持断电状态，不进行加热，桌垫上的对应点位的加热装置402的加热情况是先进行3秒预热，然后医护人员通过按动智能桌垫40上的开始加热按键使桌垫在后续的10秒内加热至65度并维持10秒自动关闭。The smart table mat 40 is equipped with an information receiving module 401a. The main function of 401 is to receive the signal of the model information and position information of the specification card. The specification card model recognition can help the smart table mat confirm and select the area to be heated in the four major areas. The smart table mat 40 is also equipped with a processor 401b. 401b is connected to all injection points on the table mat by circuits. By receiving the signal of the position information of the non-injectable point transmitted by the host end, the circuit of the point at the corresponding position of the table mat is controlled to be connected. The heating device 402 is used normally to achieve the effect of heating the point when power is turned on. If no point position information is transmitted, the power will continue to be off and no heating will be performed. The heating condition of the heating device 402 at the corresponding point on the table mat is to preheat for 3 seconds first, and then the medical staff presses the start heating button on the smart table mat 40 to heat the table mat to 65 degrees in the next 10 seconds and maintain it for 10 seconds to automatically turn it off.
作为本发明进一步的实施例，第三步：医护人员将患者后续将要使用的胰岛素注射规范卡置入智能桌垫40的对应区域，进行对注射点位的变色处理，因为规范卡上的所有的注射点位上方均涂有不可逆的热变色涂料，当温度加热到65度时原本注射点的颜色会发生变化且温度降低后颜色不会再发生变化，通过上述行为实现将规范卡上的可注射点和不可注射点的标识颜色作出明显分别从而实现不可注射点位的可视化。As a further embodiment of the present invention, in the third step: the medical staff places the insulin injection specification card that the patient will use later into the corresponding area of the smart table mat 40, and performs color change treatment on the injection points. Because all the injection points on the specification card are coated with irreversible thermochromic paint, when the temperature is heated to 65 degrees, the color of the original injection point will change and the color will no longer change after the temperature is lowered. Through the above behavior, the identification colors of the injectable points and non-injectable points on the specification card are clearly distinguished, thereby realizing the visualization of the non-injectable points.
注：上述第一到三步信息传输流程如图12所示。Note: The information transmission process of the first to third steps above is shown in Figure 12.
作为本发明进一步的实施例，第四步：将标记后的胰岛素注射规范卡110给予患者，将胰岛素轮换注射方法告知患者，并明确特殊颜色点位为不可注射点位不要进行注射。其中该套胰岛素规范注射卡的轮换注射方法：As a further embodiment of the present invention, the fourth step is to give the marked insulin injection standard card 110 to the patient, inform the patient of the insulin rotation injection method, and clearly indicate that the special color points are non-injectable points and should not be injected. The rotation injection method of the insulin standard injection card is as follows:
1.针对腹部及妊娠人群特殊的腰部和臀部上方两个注射区域的胰岛素注射规范卡：1. Insulin injection specification card for the two injection areas of the waist and buttocks for the abdomen and pregnant women:
①规范卡内的注射区域大轮换的优先级可根据字母来判断：字母A-D的对应区域为第一优先级；字母E-H的对应区域 为第二优先级；字母I-L的对应区域为第三优先级；字母M-P的对应区域为第四优先级。① The priority of the large rotation of injection areas in the specification card can be determined according to the letters: the corresponding areas of the letters A-D are the first priority; the corresponding areas of the letters E-H are the second priority; the corresponding areas of the letters I-L are the third priority; the corresponding areas of the letters M-P are the fourth priority.
②每个注射区域内的小轮换则根据数字标识来区分。这里与其他胰岛素辅助注射工具不同的是：在注射过程中始终优先选择注射区域内的最小数字为起始注射点。② The small rotations in each injection area are distinguished by digital markings. What is different from other insulin-assisted injection tools is that during the injection process, the smallest number in the injection area is always selected as the starting injection point.
例如：当A、B、C、D四列中同时存在1、2、3、4四个数字标识，则优先选择四列中所有标号为1的注射点进行注射，当所有1的注射点使用完毕后，A、B、C、D四列中存在2、3、4三个标识，再优先选择所有标号为2的注射点进行注射。同理，直到将四列中标号为4的注射点全部使用完毕，这种轮换方式相较于传统的胰岛素注射规则来说，首先点与点之间的距离更大更远，有效降低胰岛素重复注射过程皮下脂肪增生产生的可能性。For example: when there are four numbers 1, 2, 3, and 4 in the four columns A, B, C, and D, all injection points with the number 1 in the four columns are given priority for injection. When all injection points with the number 1 are used up, and there are three numbers 2, 3, and 4 in the four columns A, B, C, and D, all injection points with the number 2 are given priority for injection. Similarly, until all injection points with the number 4 in the four columns are used up, this rotation method is compared with the traditional insulin injection rules. First, the distance between points is larger and farther, which effectively reduces the possibility of subcutaneous fat hyperplasia during repeated insulin injections.
其次采用胰岛素注射轮换法则中的W/M轮换注射法这种非直线形的注射习惯，更加具有科学性。Secondly, the non-linear injection habit of the W/M rotation injection method in the insulin injection rotation rule is more scientific.
具体的，第五步：胰岛素注射规范卡的两侧具有的生物硅胶，利用生物硅胶在根据定位点定好位置后撕开两侧的薄膜与皮肤进行贴合，其中进行规范化注射方法有3种，分别为：Specifically, the fifth step: the bio-silicone on both sides of the insulin injection specification card is used to tear off the film on both sides and fit the skin after the bio-silicone is positioned according to the positioning point. There are three methods for standardized injection, namely:
方法1：如图13所示，患者贴合好后便可以选择正确轮换的数字标识的可注射的注射点位进行胰岛素的注射。注射前先将封盖在注射点位上的圆形材质扣除，透过卡面暴露出注射点的皮肤。Method 1: As shown in Figure 13, after the patient has fitted the card, he or she can select the injectable injection site with the correct rotating digital mark to inject insulin. Before injection, remove the circular material covering the injection site to expose the skin at the injection site through the card surface.
作为本发明进一步的实施例，通过生物硅胶材质的运用便可以将患者的双手解放出来进行捏皮注射等行为，其中生物硅胶的使用寿命为6年，保证患者在使用周期内都能满足与皮肤的黏合性。As a further embodiment of the present invention, the use of bio-silicone material can free the patient's hands to perform actions such as skin pinching and injection. The service life of bio-silicone is 6 years, ensuring that the patient can meet the adhesion requirements with the skin during the use period.
作为本发明进一步的实施例，注射规范卡的具体的定位点以及定位方法为：As a further embodiment of the present invention, the specific positioning points and positioning methods of the injection specification card are:
a.腹部及腰部两侧和臀部外上方的注射区域的规范注射卡的定位点为肚脐，定位完成后直接贴合即可；a. The standard injection card for the injection area of the abdomen, waist and upper buttocks is located at the navel. After positioning, it can be directly attached;
b.上臂注射区域的规范注射卡的定位点为肩关节，搭配以1厘米为间隔的定位尺辅助进行定位；b. The positioning point of the standard injection card for the upper arm injection area is the shoulder joint, and a positioning ruler with 1 cm intervals is used to assist in positioning;
定位方法为：The positioning method is:
①医护人员将卡面放置于患者合适的注射区域内，将定位尺向肩关节定位点处延伸，确定注射区域与定位点之间的距离；① The medical staff places the card surface in the appropriate injection area of the patient, extends the positioning ruler to the shoulder joint positioning point, and determines the distance between the injection area and the positioning point;
②确定注射区域的具体位置并在定位尺上做出标记。以此来帮助患者在后续的注射行为中，能够找到对应的注射区域；② Determine the specific location of the injection area and mark it on the positioning ruler. This will help the patient find the corresponding injection area in subsequent injections;
患者在后续的注射过程中只需要将医护人员标记在定位尺上的位置与肩关节进行贴合，向注射区域做延伸，最后停止的位置就是最佳注射区域；During the subsequent injection process, the patient only needs to align the position marked by the medical staff on the positioning ruler with the shoulder joint, extend it to the injection area, and the last stopping position is the best injection area;
C.腿部注射区域的规范注射卡的定位点为髋关节，搭配以1厘米为间隔的定位尺辅助进行定位。定位方法与上臂规范注射卡相同，将定位点进行置换即可。C. The positioning point of the standard injection card for the leg injection area is the hip joint, and it is assisted by a positioning ruler with 1 cm intervals. The positioning method is the same as the standard injection card for the upper arm, and the positioning point can be replaced.
作为本发明进一步的实施例，方法2：如图14所示，为帮助在这一步中患者进行更规范更严格的胰岛素注射，本套装置中还会提供搭配胰岛素注射器的胰岛素注射点位识别与控制配件。该配件的运转流程如图15所示。As a further embodiment of the present invention, method 2: as shown in FIG14 , in order to help the patient perform more standardized and strict insulin injection in this step, the device also provides an insulin injection point identification and control accessory that is matched with an insulin syringe. The operation process of the accessory is shown in FIG15 .
该配件由两部分组成：The accessory consists of two parts:
a.颜色识别传感器，连接在注射器注射端，用于识别点位的颜色是否为可注射点位的颜色；a. A color recognition sensor, connected to the injection end of the syringe, is used to identify whether the color of the point is the color of the injectable point;
b.机械控制配件，连接在注射器的注射开关处，用以根据颜色传感器识别到的信息来判断是否解锁注射开关。b. A mechanical control accessory, connected to the injection switch of the syringe, is used to determine whether to unlock the injection switch based on the information recognized by the color sensor.
传感器会提前将可注射点位的颜色录入，通过识别点位及点位周围0.5毫米的颜色与录入的颜色进行比对，判断与录入颜色的一致性。颜色识别传感器会选择是否将信号传输给位于注射开关处的机械控制配件：若颜色判断一致则传感器会传输信号给机械件的信号接收器，信号接收器接收到信号，会使机械件解锁，注射器可正常使用进行注射；若颜色判断不一致，颜色识别传感器则不会传输信号，机械控制件接收不到信号则不会解锁，胰岛素注射器开关就不能进行正常的使用从而阻止患者的注射行为。The sensor will enter the color of the injectable point in advance, and compare the color of the identification point and the color of 0.5 mm around the point with the recorded color to determine the consistency with the recorded color. The color recognition sensor will choose whether to transmit the signal to the mechanical control accessory located at the injection switch: if the color judgment is consistent, the sensor will transmit the signal to the signal receiver of the mechanical part. The signal receiver will receive the signal and unlock the mechanical part, and the syringe can be used normally for injection; if the color judgment is inconsistent, the color recognition sensor will not transmit the signal, and the mechanical control part will not unlock if it does not receive the signal, and the insulin syringe switch cannot be used normally, thereby preventing the patient from injecting.
上述方法2的信号传输如图16所示。The signal transmission of the above method 2 is shown in FIG. 16 .
作为本发明进一步的实施例，方法3：为了帮助医护人员更清晰地明确患者在注射过程中注射点的轮换情况，在该套系统中加入一套可以将注射过程中使用的所有注射点的使用顺序可视化处理的配套记录装置。As a further embodiment of the present invention, method 3: In order to help medical staff more clearly understand the rotation of injection points during the injection process of the patient, a set of supporting recording devices that can visualize the use order of all injection points used during the injection process is added to the system.
该装置的主要功能是将患者每一次注射点位的被扣除的圆形卡片按照顺序依次收集入装置内的收集仓内，收集仓内圆形卡片的颜色以及颜色的渐变排列顺序可以反映出患者在注射过程中的实际注射顺序，患者在注射周期结束后将该装置带回医院，医护人员通过观察装置收集仓内圆形卡片进行判断：首先是否有代表不可注射点位颜色的卡片在装置内，紧接着观察卡片颜色的渐变是否出现混乱，记录装置内的收集仓会出现3种情况：The main function of the device is to collect the deducted circular cards from each injection point of the patient into the collection bin in order. The colors of the circular cards in the collection bin and the color gradient arrangement order can reflect the actual injection order of the patient during the injection process. After the injection cycle, the patient takes the device back to the hospital. The medical staff observes the circular cards in the collection bin of the device to make judgments: first, whether there are cards representing the colors of non-injectable points in the device, and then observe whether the color gradient of the cards is chaotic. There are three situations in the collection bin of the recording device:
情况1：如图17所示，若存在代表不可注射点位颜色的圆形卡片存在其中，这代表患者在注射过程中存在注射点位的错误选择；Case 1: As shown in Figure 17, if there is a circular card representing the color of a non-injectable site, it means that the patient made a wrong choice of injection site during the injection process;
情况2：如图18所示，若不存在错误颜色但是颜色渐变的不顺滑或者混乱，这代表患者在注射过程中未完全按照正确的轮换注射方法进行注射；Case 2: As shown in Figure 18, if there is no wrong color but the color gradient is not smooth or chaotic, it means that the patient did not fully follow the correct rotation injection method during the injection process;
情况3：如图19所示，若仓内的圆形卡片颜色无异常，渐变正确有秩序，这代表患者的注射过程中的轮换注射习惯良好，以上三种情况都可以作为医护人员判断患者注射区域皮下脂肪增生变化情况的条件之一。Case 3: As shown in Figure 19, if there is no abnormality in the color of the circular card in the bin, and the gradient is correct and orderly, it means that the patient has a good habit of rotating injections during the injection process. The above three situations can be used as one of the conditions for medical staff to judge the changes in subcutaneous fat hyperplasia in the patient's injection area.
以上提供的3种规范化注射方法中，方法1较其他两种方法来说更快捷简便，但不能做到轮换顺序的监测和不可注射区域点位的规避。方法2较方法1来说可以做到强制性的规避不可注射区域，但不能做到方法3中的轮换顺序的监测，所以在患者在实际运用中可选择三种方法其中任意一种也可以选择方法1与方法3结合使用或者方法2与方法3结合使用。Among the three standardized injection methods provided above, method 1 is faster and simpler than the other two methods, but it cannot monitor the rotation order and avoid the points in the non-injectable area. Compared with method 1, method 2 can forcibly avoid the non-injectable area, but it cannot monitor the rotation order in method 3. Therefore, in actual use, patients can choose any of the three methods, or they can choose to use method 1 in combination with method 3 or method 2 in combination with method 3.
具体的，第六步：通过患者带回医院的胰岛素注射规范卡轮换顺序记录装置以及已经使用过一定周期的胰岛素注射规范卡，医护人员可对患者在注射周期内的注射规范化情况进行评估。Specifically, step 6: through the insulin injection specification card rotation sequence recording device brought back to the hospital by the patient and the insulin injection specification card that has been used for a certain period of time, medical staff can evaluate the patient's injection standardization during the injection cycle.
具体的，第七步：若患者后续需要继续进行胰岛素注射，重复二到五步操作根据最新的皮下脂肪增生变化情况及点位位置信息变化情况给患者重新制定带有点位区分的胰岛素注射规范卡，患者后续按照更新后的注射规范进行注射。所有点位的位置信息变化情况都同步进患者终端系统30内的档案内，形成胰岛素注射过程中患者注射部位内皮下脂肪增生变化的相关信息，后续可提供用来比对和查看。Specifically, step 7: if the patient needs to continue insulin injection in the future, repeat steps 2 to 5 to re-formulate the insulin injection specification card with point distinction for the patient according to the latest changes in subcutaneous fat hyperplasia and point location information, and the patient will be injected according to the updated injection specification in the future. The changes in the location information of all points are synchronized into the files in the patient terminal system 30, forming relevant information on the changes in subcutaneous fat hyperplasia in the patient's injection site during the insulin injection process, which can be provided for comparison and viewing later.
本具体实施例仅仅是对本发明的解释，其并不是对本发明的限制，本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改，但只要在本发明的权利要求范围内都受到专利法的保护。This specific embodiment is merely an explanation of the present invention and is not a limitation of the present invention. After reading this specification, those skilled in the art may make non-creative modifications to the present embodiment as needed. However, such modifications are protected by patent law as long as they are within the scope of the claims of the present invention.
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410383703.0ACN117959528B (en) | 2024-04-01 | 2024-04-01 | Intelligent insulin injection management device |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410383703.0ACN117959528B (en) | 2024-04-01 | 2024-04-01 | Intelligent insulin injection management device |
| Publication Number | Publication Date |
|---|---|
| CN117959528A CN117959528A (en) | 2024-05-03 |
| CN117959528Btrue CN117959528B (en) | 2024-07-02 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410383703.0AActiveCN117959528B (en) | 2024-04-01 | 2024-04-01 | Intelligent insulin injection management device |
| Country | Link |
|---|---|
| CN (1) | CN117959528B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN206295489U (en)* | 2013-12-04 | 2017-07-04 | 贝克顿·迪金森公司 | Reminder system for changing the position of the injection site |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2743027C (en)* | 2008-11-07 | 2016-04-12 | Insuline Medical Ltd. | Device and method for drug delivery |
| US20180133411A1 (en)* | 2016-11-14 | 2018-05-17 | Xiang Yu | Systems and Methods for Detecting and Visualizing Blood Vessels |
| US20220379018A1 (en)* | 2019-12-10 | 2022-12-01 | Neodyne Biosciences, Inc. | Tensioned infusion systems with removable hubs |
| CN213100087U (en)* | 2020-05-04 | 2021-05-04 | 东莞市厚街医院 | Insulin subcutaneous injection region rotation prompt card |
| CN112156283A (en)* | 2020-09-28 | 2021-01-01 | 上海中冶医院 | Insulin injection abdomen dial plate positioning device and using method |
| CN113209424A (en)* | 2021-05-17 | 2021-08-06 | 嘉兴市第一医院 | Intelligent multifunctional box for accurately positioning insulin injection and control system thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN206295489U (en)* | 2013-12-04 | 2017-07-04 | 贝克顿·迪金森公司 | Reminder system for changing the position of the injection site |
| Publication number | Publication date |
|---|---|
| CN117959528A (en) | 2024-05-03 |
| Publication | Publication Date | Title |
|---|---|---|
| US8019618B2 (en) | Report generation in a networked health-monitoring system | |
| US20050033603A1 (en) | Hospital information system | |
| US20130054150A1 (en) | System for tracking female fertility | |
| US20070038132A1 (en) | Electronic blood pressure monitor & data processing apparatus | |
| JP2010279705A (en) | Diabetes management device for analyte detection and method of selectively transferring data | |
| CN104619238A (en) | Biological information processing system, biological information measurement device, control device, method for controlling these, and storage medium | |
| CN105745653A (en) | Data Management Unit for Assisted Health Control | |
| EP1857796A1 (en) | Portable test apparatus for radiation-sensing thermometer | |
| CN117959528B (en) | Intelligent insulin injection management device | |
| CN206792395U (en) | Portable health physical examination all-in-one | |
| JP2005301816A (en) | Medical information processing system and program used for the processing system | |
| JP2019053084A (en) | Biological information measuring instrument | |
| CA2912162C (en) | Method and apparatus for characteristic monitoring in conjunction with a mode of continuously measured blood glucose values and computer program product | |
| JP4608053B2 (en) | Medical pump monitor system capable of displaying infusion circuit diagram, control method thereof, and computer-readable memory | |
| KR20170135361A (en) | Method of managing insulin injection amount by using smart phone combined with blood glucose measurement module | |
| US20060039241A1 (en) | Medical timing apparatus and method for use during pregnancy | |
| JP3753869B2 (en) | Biological information management device | |
| JP4009071B2 (en) | Physical condition management device for women | |
| CN205193077U (en) | Intelligence prothrombin time monitored control system | |
| EP1192902A1 (en) | Apparatus for managing female physical condition | |
| US6937889B2 (en) | Method and apparatus for determining pregnancy possibility | |
| JP2017086773A (en) | Biological information measuring instrument | |
| JP2002102192A (en) | Women's physical condition management device | |
| EP2789295A1 (en) | Improved measurement device, system and method | |
| CN118806247A (en) | Monitoring data display method and monitoring device |
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |